News Archives - Page 34 of 1183 - BioHealth Innovation

News

July 23, 2024

Emmes Group partners with Miimansa AI to accelerate adoption of Generative AI in clinical research

ROCKVILLE, Md., July 23, 2024 /PRNewswire/ -- Emmes Group, a leading specialty tech-enabled global contract research organization (CRO), today announced…

Andy

Love0

News

July 22, 2024

WBJ: JLL experts explore the future and changes of life sciences real estate in D.C.

In the rapidly evolving world of life sciences, the real estate sector is experiencing significant shifts and opportunities. JLL’s latest…

Andy

Love0

News

July 22, 2024

Children’s National Innovational District: Closing the ‘Valley of Death’: Pioneering – and paying for – new therapies

With the advent of life-changing cell and gene therapies (CGTs) to treat pediatric diseases, price is becoming a significant obstacle…

Andy

Love0

News

July 22, 2024

FDA Rare Disease Innovation Hub to Enhance and Advance Outcomes for Patients

By: Patrizia Cavazzoni, MD, Director, Center for Drug Evaluation and Research and Peter Marks, MD, PhD, Director, Center for Biologics…

Andy

Love0

News

July 22, 2024

Discover Innovation at the 2024 NCI Technology Showcase

The National Cancer Institute's (NCI) Technology Transfer Center invites you to the 2024 Technology Showcase on September 4th, at the…

Andy

Love0

News

July 22, 2024

Capra Biosciences Lands $7.5 Million Project Agreement To Demonstrate Platform To Rapidly Scale Pharmaceutical Ingredient Manufacturing

BioMaP-Consortium Project Agreement Will Combine Sustainable Biochemical Production with AI To Demonstrate a Scalable Platform for the Quick Manufacture of…

Andy

Love0

News

July 22, 2024

Life Sciences Real Estate and Talent Trends: Insights from Matt Gardner, Head of Life Sciences, Americas, CBRE on BioTalk

In this episode of BioTalk, Rich Bendis, President and CEO of BioHealth Innovation, Inc., speaks with Matt Gardner, Head of…

Andy

Love0

News

July 20, 2024

Gaithersburg’s Shuttle Pharma’s new drug shows promise against estrogen receptor-positive breast cancer

Shuttle Pharma’s Selective HDAC Inhibitor Exhibits ATM Activation and Modulation of ER Expression Resulting in Substantial Growth Inhibition of Estrogen…

Andy

Love0

News

July 19, 2024

Forbes: Meet The New Biotech Billionaire Putting Pig Hearts In Humans

In 1996, Martine Rothblatt’s six-year-old daughter was diagnosed with pulmonary arterial hypertension, a rare lung and heart disease without a cure. Undeterred,…

Andy

Love0

News

July 19, 2024

GUV: Only a third of US research universities have a venture fund

Most research-intensive universities in the US — including globally renowned institutions such as Stanford, Cornell and Yale — do not…

Andy

Love0

News

Emmes Group partners with Miimansa AI to accelerate adoption of Generative AI in clinical research

WBJ: JLL experts explore the future and changes of life sciences real estate in D.C.

Children’s National Innovational District: Closing the ‘Valley of Death’: Pioneering – and paying for – new therapies

FDA Rare Disease Innovation Hub to Enhance and Advance Outcomes for Patients

Discover Innovation at the 2024 NCI Technology Showcase

Capra Biosciences Lands $7.5 Million Project Agreement To Demonstrate Platform To Rapidly Scale Pharmaceutical Ingredient Manufacturing

Life Sciences Real Estate and Talent Trends: Insights from Matt Gardner, Head of Life Sciences, Americas, CBRE on BioTalk

Gaithersburg’s Shuttle Pharma’s new drug shows promise against estrogen receptor-positive breast cancer

Forbes: Meet The New Biotech Billionaire Putting Pig Hearts In Humans

GUV: Only a third of US research universities have a venture fund

About BioHealth Innovation

Contact

Connect

News

About BioHealth Innovation

Contact

Connect

Search